Latest News & Updates
Breaking News
1 hour ago
Team Pharma Now
Other trending news you may like to read
Eyestem Receives CDSCO Approval to Initiate Phase 2 Randomized, Controlled Human Trials of Eyecyte-RPE™
Eyestem receives CDSCO approval to begin Phase 2 trials of Eyecyte-RPE for geographic atrophy in dry age-related macular degeneration.
Team Pharma Now
GRI Bio Secures New U.S. Patent For Novel Immunomodulatory Compound Compositions Targeting Inflammatory, Fibrotic, And Autoimmune Diseases
GRI Bio expands its IP portfolio with a newly issued US patent supporting its NKT cell immunomodulation platform.
Simantini Singh Deo
Cogent Biosciences Secures FDA Breakthrough Therapy Status For Bezuclastinib + Sunitinib Combo To Treat Gastrointestinal Stromal Tumors (GIST)
Cogent’s bezuclastinib–sunitinib combo receives FDA Breakthrough designation for treating advanced GIST after imatinib.
Simantini Singh Deo
Akari Therapeutics Files New U.S. Provisional Patent For AKTX-102, A First-In-Class CEACAM5-Targeting ADC Powered By PH1 Spliceosome-Modulating Payload
Akari expands its ADC pipeline with a new patent filing for AKTX-102, targeting CEACAM5 using a novel RNA-splicing payload.
Simantini Singh Deo
